Show simple item record

dc.contributorLienhard, Dina A.
dc.creatorSantora, Emily
dc.creatorGuerrero, Anna
dc.date.accessioned2019-11-30T19:50:31Z
dc.date.available2019-11-30T19:50:31Z
dc.date.created2019-11-30
dc.identifier.urihttps://hpsrepository.asu.edu/handle/10776/13136
dc.description.abstractLeuprolide acetate, or leuprorelin, is a manufactured drug that has been prescribed as a treatment for endometriosis, a medical condition in which body tissue that typically lines the uterus grows outside of the uterus, since 1989. Leuprorelin is a modified version of a gonadotropin-releasing hormone, a type of hormone that helps regulate the female menstrual cycle. The drug inhibits the production of estrogen, a female sex hormone that enables endometrial gland growth. After two weeks of injections, leuprorelin stops the production of estrogen, and without estrogen, endometrial glands become inactive. That decreases the growth of uterine tissue outside of the uterus, which helps decrease the pain associated with endometriosis. Although physicians commonly prescribe leuprorelin as of 2019, women with endometriosis have reported adverse side effects and health complications.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoen_USen_US
dc.language.isoen_USen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rightsCopyright Arizona Board of Regentsen_US
dc.subjectConcepten_US
dc.subject.lcshEndometriosisen_US
dc.subject.lcshEndometriumen_US
dc.subject.lcshDrug utilizationen_US
dc.subject.lcshDrugs--Administrationen_US
dc.subject.lcshUterusen_US
dc.subject.lcshUterus--Diseasesen_US
dc.subject.lcshUterus--Abnormalitiesen_US
dc.subject.lcshUterus--Examinationen_US
dc.subject.lcshInjectionsen_US
dc.subject.lcshUterus--Diseases--Diagnosisen_US
dc.subject.lcshPelvic painen_US
dc.subject.lcshPelvis--Painen_US
dc.subject.lcshFertilization in vitroen_US
dc.subject.meshEndometriosisen_US
dc.subject.meshFemale Urogenital Diseasesen_US
dc.subject.meshPelvic Painen_US
dc.subject.meshLeuprolideen_US
dc.titleLeuprorelin as a Treatment for Endometriosisen_US
dc.typeArticleen_US
dc.typeTexten_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.subject.embryoProcessesen_US
dc.subject.tagendometriosisen_US
dc.subject.tagendometriumen_US
dc.subject.tagendometriotic lesionsen_US
dc.subject.tagpelvic painen_US
dc.subject.tagleuprorelinen_US
dc.subject.tagleuprolide acetateen_US
dc.subject.tagLupronen_US
dc.subject.taguterusen_US
dc.subject.tagdiseaseen_US
dc.description.typeArticlesen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record